Premium
The PCAST Report: Impact and Implications for the Pharmaceutical Industry
Author(s) -
Morris S A,
Rosenblatt M,
Orloff J J,
LewisHall F,
Waldstreicher J
Publication year - 2013
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1038/clpt.2013.93
Subject(s) - clinical pharmacology , action (physics) , pharmaceutical industry , face (sociological concept) , engineering ethics , pharmacology , medicine , public relations , political science , business , engineering , sociology , social science , physics , quantum mechanics
The President's Council of Advisors on Science and Technology (PCAST) report sets out an ambitious goal: to double the output of innovative, new medicines with increased efficacy and safety within the next 10–15 years. If attainable, this could change the face of medicine and bring great benefit to society. Clear leadership, commitment to action, and unprecedented collaboration will be essential if the goal of the report is to be realized. Clinical Pharmacology & Therapeutics (2013); 94 3, 300–302. doi: 10.1038/clpt.2013.93